Evidence map›Paper›PMID 32856318›Full record

ArticleAnnals of neurology2020

PIK3R2/Pik3r2 Activating Mutations Result in Brain Overgrowth and EEG Changes.

Xiuyu Shi, Youngshin Lim, Abigail K Myers, Brenna L Stallings, Almedia Mccoy, Jordan Zeiger, Joshua Scheck, Ginam Cho, Eric D Marsh, Ghayda M Mirzaa and 2 more

Open access · greenAbstract read
In one paragraph

Article in Annals of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Generation of FLAG-tagged Arx knock-in mouse model.Genesis (New York, N.Y. : 2000) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. The Genetic Landscape of Polymicrogyria.Annals of Indian Academy of Neurology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Xiuyu Shi *State Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen University, Xiamen, China.ORCID 0000-0002-3075-6568
Youngshin Lim *Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.ORCID 0000-0002-7842-3244
Abigail K MyersDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Brenna L StallingsDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Almedia MccoyDepartments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Jordan ZeigerCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Joshua ScheckCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Ginam ChoDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Eric D MarshDepartments of Neurology and Pediatrics, Division of Child Neurology, Children's Hospital of Philadelphia, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.ORCID 0000-0003-3264-0902
Ghayda M MirzaaCenter for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA, USA.
Tao TaoState Key Laboratory of Stress Cell Biology, School of Life Sciences, Xiamen University, Xiamen, China.
Jeffrey A GoldenDepartment of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Brigham and Women's Hospital · USChildren's Hospital of Philadelphia · USUniversity of Washington · USXiamen University · CN

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI JENNIFER W MACK · 1985 to 2026
$330.6M
The Harvard Clinical and Translational Science CenterUL1TR002541 · NCATS · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2018 to 2022
$93.0M
Super-Resolution ImagingP30NS072030 · NINDS · HARVARD MEDICAL SCHOOL · PI REGEHR, WADE G · 2011 to 2020
$5.8M
Precision models of ARX-associated neurodevelopmental disordersR01NS113516 · NINDS · UNIVERSITY OF TEXAS SAN ANTONIO · PI GOLDEN, JEFFREY A, HSIEH, JENNY · 2019 to 2023
$2.6M
Arx Associated Transcriptional Networks in Neocortical DevelopmentR01NS100007 · NINDS · CEDARS-SINAI MEDICAL CENTER · PI GOLDEN, JEFFREY A · 2018 to 2021
$1.5M
Genes and pathways underlying brain overgrowth and focal cortical malformationsK08NS092898 · NINDS · SEATTLE CHILDREN'S HOSPITAL · PI MIRZAA, GHAYDA · 2015 to 2019
$930k
NCATS NIH HHS UL1 TR002541NCI NIH HHS P30 CA006516NINDS NIH HHS K08 NS092898NINDS NIH HHS P30 NS072030NINDS NIH HHS R01 NS100007NINDS NIH HHS R01 NS113516
6 · The paper itself

Abstract

objectiveMutations in phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) complex have been associated with a broad spectrum of brain and organ overgrowth syndromes. For example, mutations in phosphatidylinositol-3-kinase regulatory subunit 2 (PIK3R2) have been identified in human patients with megalencephaly polymicrogyria polydactyly hydrocephalus (MPPH) syndrome, which includes brain overgrowth. To better understand the pathogenesis of PIK3R2-related mutations, we have developed and characterized a murine model.

methodsWe generated a knock-in mouse model for the most common human PIK3R2 mutation, p.G373R (p.G367R in mice) using CRISPR/Cas9. The mouse phenotypes, including brain size, seizure activity, cortical lamination, cell proliferation/size/density, interneuron migration, and PI3K pathway activation, were analyzed using standard methodologies. For human patients with PIK3R2 mutations, clinical data (occipitofrontal circumference [OFC] and epilepsy) were retrospectively obtained from our clinical records (published / unpublished).

resultsThe PI3K-AKT pathway was hyperactivated in these mice, confirming the p.G367R mutation is an activating mutation in vivo. Similar to human patients with PIK3R2 mutations, these mice have enlarged brains. We found cell size to be increased but not cell numbers. The embryonic brain showed mild defects in cortical lamination, although not observed in the mature brain. Furthermore, electroencephalogram (EEG) recordings from mutant mice showed background slowing and rare seizures, again similar to our observations in human patients.

interpretationWe have generated a PIK3R2 mouse model that exhibits megalencephaly and EEG changes, both of which overlap with human patients. Our data provide novel insight into the pathogenesis of the human disease caused by PIK3R2 p.G373R mutation. We anticipate this model will be valuable in testing therapeutic options for human patients with MPPH. ANN NEUROL 2020;88:1077-1094.

Indexed as

AnimalsBrainElectroencephalographyEpilepsyFemaleGene Knock-In TechniquesHumansMaleMegalencephalyMiceMutationPhosphatidylinositol 3-KinasesProteasome Endopeptidase ComplexSeizuresSignal TransductionSyndromePhosphatidylinositol 3-Kinasesphosphoinositol-3 kinase regulatory subunit 2, mouseProteasome Endopeptidase ComplexPsmf1 protein, mouse

Identifiers

PMID32856318
PMCPMC8176885
OpenAlexW3082610805

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.